Pharm/Biotech
Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 

 

 

Title:  Polymers with controlled physical state and bioerodibility

United States Patent:  5,968,543

Inventors:  Heller; Jorge (Woodside, CA); Ng; Steven Y. (San Francisco, CA)

Assignee:  Advanced Polymer Systems, Inc. (Redwood City, CA)

Appl. No.:  986035

Filed:  December 5, 1997

Abstract

Polymers useful as orthopedic implants or vehicles for the sustained delivery of pharmaceutical, cosmetic and agricultural agents are prepared in such a manner that the rate and degree to which they are hydrolyzed can be controlled without addition of exogenous acid. This control results from the incorporation of esters of short-chain .alpha.-hydroxy acids such as esters of glycolic acid, lactic acid or glycolic-co-lactic acid copolymer into the polymer chain and variation of the amount of these esters relative to the polymer as a whole.

SUMMARY OF THE INVENTION

It has now been discovered that polymers useful as orthopedic implants or vehicles for the sequestration and sustained delivery of drugs, cosmetic agents and other beneficial agents can be prepared in such a manner that the rate and degree to which they are hydrolyzed by contact with bodily fluids at normal body temperature and pH can be controlled without addition of exogenous acid. This discovery resides in the incorporation of esters of short-chain .alpha.-hydroxy acids such as esters of glycolic acid, lactic acid or glycolic-co-lactic acid copolymer into the polymer chain and variation of the amount of these esters relative to the polymer as a whole.

In the presence of water, these esters, when incorporated into the polymer chain, are readily hydrolyzed at a body temperature of 37oC. and a physiological pH, in particular at a pH of 7.4, to produce the corresponding .alpha.-hydroxy acids. The .alpha.-hydroxy acids then act as an acidic excipient to control the hydrolysis rate of the polymer. When the polymer is used as a vehicle or matrix entrapping an active agent, the hydrolysis of the polymer causes release of the active agent.

In addition, the mechano-physical state of the polymer may also be controlled. This is achieved by the inclusion of the residues of certain diols in selected proportions relative to the polymer as a whole. For example, a high content of the residue of trans-cyclohexanedimethanol relative to a "soft" diol (definition of which is given below) produces a relatively rigid polymer chain and a more solid substance, and by decreasing the trans-cyclohexanedimethanol content relative to the "soft" diol, the polymer will change progressively through the stages of a rigid thermoplastic, a soft thermoplastic, a low melting solid to an ointment-like (viscous liquid) material, and any stage in between.

The polymers of the present invention are prepared by condensation reactions between diketene acetals and polyols, preferably diols, and the variation in mechano-physical state and rate of hydrolysis (bioerodibility) is achieved by the selection and use of combinations of different types of diols.

Claim 1 of 30 Claims

1. A polymer of Formula I 

where R* is a C1 -C4 alkyl; each A is selected from the group consisting of --O--R1 --, --O--R2 --, or (--O--R3)q --, where q is 1 to 20;

n is at least 5; and

R1 is

in which p is 1-10;

R4 is hydrogen or a C1 -C6 alkyl; and

R5 is 

where: s is 1 to 100;

t is 1 to 12;

R2 is 

when q is 1, R3 is 

in which: x is 1 to 100;

y is 1 to 12;

R6 and R7 are independently a C1 -C12 alkylene;

R8 is hydrogen or a C1 -C6 alkyl; and

R9 is a C1 -C6 alkyl; or

R8 and R9 taken together are a C3 -C10 alkylene; and

when q is 2 to 20, each R3 may be the same or different and is 

where x, y, R6, R7, R8 and R9 are as defined above, R10 is

hydrogen or a C1 -C4 alkyl, and R11 is a C1 -C4 alkyl; provided that the polymer comprises at least 0.1 mole percent of units in which A is --O--R1 --.

____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.

 

 

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]